Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry

Journal of Proteome Research

Volumn 13, Issue 12, 2014, Pages 5715-5723

  Huang, Yan ^a   Chen, Guoyou ^b,c   Liu, Xinyu ^b   Shao, Yaping ^b   Gao, Peng ^b   Xin, Chenchen ^a   Cui, Zhenze ^a   Zhao, Xinjie ^b   Xu, Guowang ^b  

^a Dalian Friendship Hospital   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Atopic dermatitis; eicosanoids; immunoglobulin E; LC MS; metabolomics

Indexed keywords

BILE ACID; BILE ACID CONJUGATE; CARNITINE; CYTOCHROME P450; FATTY ACID; ICOSANOID; IMMUNOGLOBULIN E; LACTIC ACID; LEUKOTRIENE B4; PROSTAGLANDIN; BIOLOGICAL MARKER;

AMINO ACID METABOLISM; ARTICLE; ATOPIC DERMATITIS; BILE ACID METABOLISM; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HUMAN; INFLAMMATION; MALE; MASS SPECTROMETRY; METABOLOMICS; PRESCHOOL CHILD; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; DERMATITIS, ATOPIC; INFANT; LIQUID CHROMATOGRAPHY; METABOLISM; METABOLOME; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; CARNITINE; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DERMATITIS, ATOPIC; EICOSANOIDS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; LACTIC ACID; LEUKOTRIENE B4; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PROSTAGLANDINS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84915819372     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5007069     Document Type: Article

References (57)

1. Flohr, C.; Mann, J. New insights into the epidemiology of childhood atopic dermatitis Allergy 2014, 69 (1) 3-16
2. Xu, F.; Yan, S.; Li, F.; Cai, M.; Chai, W.; Wu, M.; Fu, C.; Zhao, Z.; Kan, H.; Kang, K.; Xu, J. Prevalence of childhood atopic dermatitis: An urban and rural community-based study in Shanghai, China PLoS One 2012, 7, 5
3. Bieber, T. Atopic dermatitis Ann. Dermatol. 2010, 22 (2) 125-137
4. Cox, H. E.; Moffatt, M. F.; Faux, J. A.; Walley, A. J.; Coleman, R.; Trembath, R. C.; Cookson, W.; Harper, J. I. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor Br. J. Dermatol. 1998, 138 (1) 182-187
5. Galli, S. J.; Grimbaldeston, M.; Tsai, M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity Nat. Rev. Immunol. 2008, 8 (6) 478-U14
6. Hanifin, J. M.; Rajka, G. Diagnostic features of atopic-dermatitis Acta Derm.-Venereol. 1980, 44-47
7. Nicholson, J. K.; Holmes, E.; Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care Nat. Rev. Microbiol. 2005, 3 (5) 431-438
8. Ye, G.; Liu, Y.; Yin, P.; Zeng, Z.; Huang, Q.; Kong, H.; Lu, X.; Zhong, L.; Zhang, Z.; Xu, G. Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics J. Proteome Res. 2014, 13 (4) 1994-2004
9. Huang, Q.; Tan, Y.; Yin, P.; Ye, G.; Gao, P.; Lu, X.; Wang, H.; Xu, G. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics Cancer Res. 2013, 73 (16) 4992-5002
10. Assfalg, M.; Bortoletti, E.; D'Onofrio, M.; Pigozzi, R.; Molinari, H.; Boner, A. L.; Peroni, D. G.; Piacentini, G. L. An exploratory H-1-nuclear magnetic resonance metabolomics study reveals altered urine spectral profiles in infants with atopic dermatitis Br. J. Dermatol. 2012, 166 (5) 1123-1125
11. Van Smeden, J.; Boiten, W. A.; Hankemeier, T.; Rissmann, R.; Bouwstra, J. A.; Vreeken, R. J. Combined LC/MS-platform for analysis of all major stratum corneum lipids, and the profiling of skin substitutes Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2014, 1841 (1) 70-79
12. van Smeden, J.; Hoppel, L.; van der Heijden, R.; Hankemeier, T.; Vreeken, R. J.; Bouwstra, J. A. LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery J. Lipid Res. 2011, 52 (6) 1211-1221
13. Funk, C. D. Prostaglandins and leukotrienes: Advances in eicosanoid biology Science 2001, 294 (5548) 1871-1875
14. Mihaly, J.; Gericke, J.; Toerocsik, D.; Gaspar, K.; Szegedi, A.; Ruehl, R. Reduced lipoxygenase and cyclooxygenase mediated signaling in PBMC of atopic dermatitis patients Prostaglandins Other Lipid Mediators 2013, 107, 35-42
15. Zhao, X.; Xu, F.; Qi, B.; Hao, S.; Li, Y.; Li, Y.; Zou, L.; Lu, C.; Xu, G.; Hou, L. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry J. Proteome Res. 2014, 13 (2) 1101-1111
16. Yang, J.; Eiserich, J. P.; Cross, C. E.; Morrissey, B. M.; Hammock, B. D. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients Free Radical Biol. Med. 2012, 53 (1) 160-171
17. Saeed, A. I.; Sharov, V.; White, J.; Li, J.; Liang, W.; Bhagabati, N.; Braisted, J.; Klapa, M.; Currier, T.; Thiagarajan, M.; Sturn, A.; Snuffin, M.; Rezantsev, A.; Popov, D.; Ryltsov, A.; Kostukovich, E.; Borisovsky, I.; Liu, Z.; Vinsavich, A.; Trush, V.; Quackenbush, J. TM4: A free, open-source system for microarray data management and analysis Biotechniques 2003, 34 (2) 374-378
18. Chen, J.; Zhao, X.; Fritsche, J.; Yin, P.; Schmitt-Kopplin, P.; Wang, W.; Lu, X.; Haring, H. U.; Schleicher, E. D.; Lehmann, R.; Xu, G. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information Anal. Chem. 2008, 80 (4) 1280-1289
19. Harizi, H.; Corcuff, J.-B.; Gualde, N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology Trends Mol. Med. 2008, 14 (10) 461-469
20. Russell, D. W. The enzymes, regulation, and genetics of bile acid synthesis Annu. Rev. Biochem. 2003, 72, 137-174
21. 2+ ions J. Lipid Res. 1992, 33 (5) 617-626
22. Lima, J. J.; Zhang, S.; Grant, A.; Shao, L. H.; Tantisira, K. G.; Allayee, H.; Wang, L. W.; Sylvester, J.; Holbrook, J.; Wise, R.; Weiss, S. T.; Barnes, K. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma Am. J. Respir. Crit. Care Med. 2006, 173 (4) 379-385
23. Tager, A. M.; Bromley, S. K.; Medoff, B. D.; Islam, S. A.; Bercury, S. D.; Friedrich, E. B.; Carafone, A. D.; Gerszten, R. E.; Luster, A. D. Leukotriene B-4 receptor BLT1 mediates early effector T cell recruitment Nat. Immunol. 2003, 4 (10) 982-990
24. Ruzicka, T.; Simmet, T.; Peskar, B. A.; Ring, J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic-dermatitis and psoriasis J. Invest. Dermatol. 1986, 86 (2) 105-108
25. Dyer, D. G.; Dunn, J. A.; Thorpe, S. R.; Bailie, K. E.; Lyons, T. J.; McCance, D. R.; Baynes, J. W. Accumulation of maillard reaction-products in skin collagen in diabetes and aging J. Clin. Invest. 1993, 91 (6) 2463-2469
26. Montuschi, P.; Peters-Golden, M. L. Leukotriene modifiers for asthma treatment Clin. Exp. Allergy 2010, 40 (12) 1732-1741
27. Duroudier, N. P.; Tulah, A. S.; Sayers, I. Leukotriene pathway genetics and pharmacogenetics in allergy Allergy 2009, 64 (6) 823-839
28. Marks, A. K.; Kitson, A. P.; Shaw, B.; Mutch, D. M.; Stark, K. D. Stearoyl-CoA desaturase 1, elongase 6 and their fatty acid products and precursors are altered in ovariectomized rats with 17β-estradiol and progesterone treatment Prostaglandins, Leukotrienes Essent. Fatty Acids 2013, 89 (Issues 2-3) 89-96
29. Schroeder, R.; Xue, L.; Konya, V.; Martini, L.; Kampitsch, N.; Whistler, J. L.; Ulven, T.; Heinemann, A.; Pettipher, R.; Kostenis, E. PGH(1), the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2 PLoS One 2012, 7 (3) e33329
30. Jenkins, C. M.; Cedars, A.; Gross, R. W. Eicosanoid signalling pathways in the heart Cardiovasc. Res. 2009, 82 (2) 240-249
31. Anderson, G. D.; Keys, K. L.; De Ciechi, P. A.; Masferrer, J. L. Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis Inflamm. Res. 2009, 58 (2) 109-117
32. Seino, S.; Tanaka, Y.; Honma, T.; Yanaka, M.; Sato, K.; Shinohara, N.; Ito, J.; Tsuduki, T.; Nakagawa, K.; Miyazawa, T.; Ikeda, I. Atopic dermatitis causes lipid accumulation in the liver of NC/Nga mouse J. Clin. Biochem. Nutr. 2012, 50 (2) 152-157
33. Flaquer, A.; Heinzmann, A.; Rospleszcz, S.; Mailaparambil, B.; Dietrich, H.; Strauch, K.; Grychtol, R. Association study of mitochondrial genetic polymorphisms in asthmatic children Mitochondrion 2014, 14, 49-53
34. Chodaczek, G.; Bacsi, A.; Dharajiya, N.; Sur, S.; Hazra, T. K.; Boldogh, I. Ragweed pollen-mediated IgE-independent release of biogenic amines from mast cells via induction of mitochondrial dysfunction Mol. Immunol. 2009, 46 (13) 2505-2514
35. Lowell, B. B.; Shulmanz, G. I. Mitochondrial dysfunction and type 2 diabetes Science 2005, 307 (5708) 384-387
36. Chan, D. C. Mitochondria: Dynamic organelles in disease, aging, and development Cell 2006, 125 (7) 1241-1252
37. Ohanian, J.; Ohanian, V. Sphingolipids in mammalian cell signalling Cell. Mol. Life Sci. 2001, 58 (14) 2053-2068
38. Sahle, F. F.; Lange, S.; Dobner, B.; Wohlrab, J.; Neubert, R. H. H. Development and validation of LC/ESI-MS method for the detection and quantification of exogenous ceramide NP in stratum corneum and other layers of the skin J. Pharm. Biomed. 2012, 60, 7-13
39. Jensen, J. M.; Folster-Holst, R.; Baranowsky, A.; Schunck, M.; Winoto-Morbach, S.; Neumann, C.; Schutze, S.; Proksch, E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis J. Invest. Dermatol. 2004, 122 (6) 1423-1431
40. Murata, Y.; Ogata, J.; Higaki, Y.; Kawashima, M.; Yada, Y.; Higuchi, K.; Tsuchiya, T.; Kawaminami, S.; Imokawa, G. Abnormal expression of sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency? J. Invest. Dermatol. 1996, 106 (6) 1242-1249
41. Newgard, C. B. Interplay between lipids and branched-chain amino acids in development of insulin resistance Cell Metab. 2012, 15 (5) 606-614
42. Calder, P. C. Branched-chain amino acids and immunity J. Nutr. 2006, 136 (1) 288S-293S
43. Kimball, S. R.; Jefferson, L. S. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis J. Nutr. 2006, 136 (1) 227S-231S
44. Wu, G. Y.; Jaeger, L. A.; Bazer, F. W.; Rhoads, J. M. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications J. Nutr. Biochem. 2004, 15 (8) 442-451
45. Guzik, T. J.; Korbut, R.; Adamek-Guzik, T. Nitric oxide and superoxide in inflammation and immune regulation J. Physiol. Pharmacol. 2003, 54 (4) 469-487
46. Akdeniz, N.; Aktas, A.; Erdem, T.; Akyuz, M.; Ozdemir, S. Nitric oxide levels in atopic dermatitis Pain Clinic 2004, 16 (4) 401-405
47. Hierholzer, C.; Kalff, J. C.; Billiar, T. R.; Bauer, A. J.; Tweardy, D. J.; Harbrecht, B. G. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock Am. J. Physiol.: Gastrointest. Liver Physiol. 2004, 286 (2) G225-G233
48. Guzik, T. J.; Adamek-Guzik, T.; Czerniawska-Mysik, G.; Dembinska-Kiec, A. Nitric oxide metabolite levels in children and adult patients with atopic eczema/dermatitis syndrome Allergy 2002, 57 (9) 856-856
49. Kubes, P.; McCafferty, D. M. Nitric oxide and intestinal inflammation Am. J. Med. 2000, 109 (2) 150-158
50. Ingber, A.; Cohen, Y.; Krimsky, M.; Yedgar, S. A novel treatment of contact dermatitis by topical application of phospholipase A(2) inhibitor: A double-blind placebo-controlled pilot study Int. J. Immunopathol. Pharmacol. 2007, 20 (1) 191-195
51. Maury, E.; Julie, S.; Charveron, M.; Gall, Y.; Chap, H. Lipids and skin inflammation: role of phospholipases A2 Pathol. Biol. 2003, 51 (5) 248-252
52. Dan, P.; Rosenblat, G.; Yedgar, S. Phospholipase A(2) activities in skin physiology and pathology Eur. J. Pharmacol. 2012, 691 (1-3) 1-8
53. Yamamoto, M.; Haruna, T.; Imura, K.; Hikita, I.; Furue, Y.; Higashino, K.; Gahara, Y.; Deguchi, M.; Yasui, K.; Arimura, A. Inhibitory effect of a potent and selective cytosolic phospholipase A(2)alpha inhibitor RSC-3388 on skin inflammation in mice Pharmacology 2008, 81 (4) 301-311
54. Spector, A. A.; Fang, X.; Snyder, G. D.; Weintraub, N. L. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog. Lipid Res. 2004, 43 (1) 55-90
55. Roman, R. J. P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol. Rev. 2002, 82 (1) 131-185
56. Satarug, S.; Nishijo, M.; Lasker, J. M.; Edwards, R. J.; Moore, M. R. Kidney dysfunction and hypertension: Role for cadmium, P450 and heme oxygenases? Tohoku J. Exp. Med. 2006, 208 (3) 179-202
57. Theken, K. N.; Schuck, R. N.; Edin, M. L.; Tran, B.; Ellis, K.; Bass, A.; Lih, F. B.; Tomer, K. B.; Poloyac, S. M.; Wu, M. C.; Hinderliter, A. L.; Zeldin, D. C.; Stouffer, G. A.; Lee, C. R. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease Atherosclerosis 2012, 222 (2) 530-536